Cone degeneration is triggered by the absence of USH1 proteins but prevented by antioxidant treatments

Sci Rep. 2018 Jan 31;8(1):1968. doi: 10.1038/s41598-018-20171-0.

Abstract

Usher syndrome type 1 (USH1) is a major cause of inherited deafness and blindness in humans. The eye disorder is often referred to as retinitis pigmentosa, which is characterized by a secondary cone degeneration following the rod loss. The development of treatments to prevent retinal degeneration has been hampered by the lack of clear evidence for retinal degeneration in mutant mice deficient for the Ush1 genes, which instead faithfully mimic the hearing deficit. We show that, under normal housing conditions, Ush1g-/- and Ush1c-/- albino mice have dysfunctional cone photoreceptors whereas pigmented knockout animals have normal photoreceptors. The key involvement of oxidative stress in photoreceptor apoptosis and the ensued retinal gliosis were further confirmed by their prevention when the mutant mice are reared under darkness and/or supplemented with antioxidants. The primary degeneration of cone photoreceptors contrasts with the typical forms of retinitis pigmentosa. Altogether, we propose that oxidative stress probably accounts for the high clinical heterogeneity among USH1 siblings, which also unveils potential targets for blindness prevention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Apoptosis
  • Carrier Proteins / metabolism*
  • Cell Cycle Proteins
  • Cytoskeletal Proteins
  • Darkness
  • Diet
  • Glial Fibrillary Acidic Protein / metabolism
  • Gliosis / pathology
  • Housing, Animal
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Nerve Tissue Proteins / metabolism*
  • Opsins / metabolism
  • Phenotype
  • Retinal Cone Photoreceptor Cells / drug effects
  • Retinal Cone Photoreceptor Cells / pathology*
  • Retinal Degeneration / drug therapy*
  • Retinal Degeneration / pathology
  • Retinal Degeneration / prevention & control*
  • Taurine / administration & dosage

Substances

  • Antioxidants
  • Carrier Proteins
  • Cell Cycle Proteins
  • Cytoskeletal Proteins
  • Glial Fibrillary Acidic Protein
  • Nerve Tissue Proteins
  • Opsins
  • Sans protein, mouse
  • Ush1c protein, mouse
  • Taurine